PMID: 9646988Jul 1, 1998Paper

Management of parapneumonic effusions

Clinics in Chest Medicine
R Light, R M Rodriguez

Abstract

When a patient with a parapneumonic pleural effusion is first evaluated, a therapeutic thoracentesis should be performed if more than a minimal amount of pleural fluid is present. Fluid obtained at the therapeutic thoracentesis should be gram-stained and cultured and analyzed for glucose, pH, LDH, white blood cells, and differential cell count. If the fluid cannot be drained because of loculations, a chest tube should be inserted and thrombolytic agents administered. If the pleural fluid recurs after the initial therapeutic thoracentesis but the patient is doing well clinically and the initial pleural fluid glucose was greater than 60 mg/dL; the pH, greater than 7.2; the LDH, less than three times the upper normal limit for serum and the cultures are negative; he or she can be observed. If one or more of the aforementioned criteria are not met, a second therapeutic thoracentesis should be performed, with repeat diagnostic evaluations of the pleural fluid. If the fluid recurs a second time, a small chest tube should be placed if the pleural fluid glucose and pH were lower and the LDH higher on the second thoracentesis than on the first thoracentesis. Patients with loculated-parapneumonic effusions should be treated with tube tho...Continue Reading

References

Oct 1, 1989·Journal of the History of Medicine and Allied Sciences·P D Olch
May 1, 1989·Chest·S A Sahn, R W Light
Oct 1, 1988·Radiology·S G SilvermanJ T Ferrucci
Nov 1, 1973·Chest·R W LightP C Luchsinger
Apr 1, 1993·The American Review of Respiratory Disease·C StrangeS A Sahn
Jun 1, 1996·The Annals of Thoracic Surgery·T A Angelillo MackinlayJ Emery
Apr 1, 1996·QJM : Monthly Journal of the Association of Physicians·A D FergusonC R Swinburn
Jan 1, 1997·American Journal of Respiratory and Critical Care Medicine·D BourosN M Siafakas

❮ Previous
Next ❯

Citations

May 31, 2008·Current Infectious Disease Reports·Shi-Ping LuhChen Cheng-Ren
Aug 7, 2002·Internal Medicine Journal·R J Cameron
May 6, 1999·Current Opinion in Pulmonary Medicine·H C Mwandumba, N J Beeching
Apr 27, 2000·Current Opinion in Pulmonary Medicine·H C Mwandumba, N J Beeching
Nov 13, 2003·Archives of Disease in Childhood·A K BaranwalL Kumar
May 12, 2000·BMJ : British Medical Journal·G J PeekG Cooper
Mar 6, 2007·Respiration; International Review of Thoracic Diseases·Angelika Reissig, Claus Kroegel
Oct 3, 2002·American Journal of Respiratory and Critical Care Medicine·Steven IdellEdmund Miller
Oct 1, 2007·Journal of Minimal Access Surgery·Michael A WaitMichael J Dimaio
Jan 1, 2007·Annals of Thoracic Medicine·Preetam Rajgopal Acharya, Kusum V Shah
Feb 23, 2007·Revista portuguesa de pneumologia·Sara MartinsTeresa Bandeira
Apr 11, 2012·Emergency Medicine Clinics of North America·Erin Weldon, Jen Williams
Mar 16, 2005·Revue des maladies respiratoires·P AssoulineG Oliviero
Dec 3, 2010·European Journal of Clinical Investigation·Irene TsilioniTheodoros S Kiropoulos
Mar 18, 1999·Baillière's Clinical Gastroenterology·B KoletzkoP Socha
Aug 5, 2000·Clinical Radiology·S E KearneyF V Gleeson
May 29, 2015·Current Opinion in Pulmonary Medicine·Stéphane JouneauBenoit Desrues
Jan 18, 2015·Revue des maladies respiratoires·J LetheulleS Jouneau
Dec 17, 2016·Journal of Bronchology & Interventional Pulmonology·Georgia HardavellaNikolaos Anastasiou
Feb 23, 2019·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·A LehtomäkiJ Khan
May 27, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Harry Karmouty QuintanaNicolau Beckmann
Oct 22, 2020·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Charalampos VarsamasFoteini Malli
Aug 16, 2018·Prilozi·Sanja Petrusevska MarinkovicAnkica Anastasovska
May 12, 2021·Expert Review of Anti-infective Therapy·Susanna EspositoNicola Principi
Jun 25, 2020·Reviews on Recent Clinical Trials·Maria Teresa CongedoMariano Alberto Pennisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.